Literature DB >> 2816358

Quality of life of adults with growth hormone deficiency: a controlled study.

S Björk1, B Jönsson, O Westphal, J E Levin.   

Abstract

The quality of life of 23 adults with growth hormone deficiency (GHD) who had received growth hormone (GH) therapy was compared with that of 47 normal individuals in a control group. The GHD group had a poorer quality of life than the control group. Statistically significant differences were found between the groups for social isolation, physical mobility, sleep, and emotional status. More individuals in the control group had a driving licence and were married than in the GHD group.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2816358     DOI： 10.1111/j.1651-2227.1989.tb11242.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand Suppl        ISSN： 0300-8843


  20 in total

Review 1.  Long-term growth hormone replacement therapy in hypopituitary adults.

Authors:  Johan Verhelst; Roger Abs
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Psychosocial effects of short stature.

Authors:  David Zlotkin; Surendra K Varma
Journal:  Indian J Pediatr       Date:  2006-01       Impact factor: 1.967

Review 3.  Optimum use of growth hormone in children.

Authors:  Z Laron; O Butenandt
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546

Review 4.  Quality-of-life assessment of adults with growth hormone deficiency. Implications for drug therapy.

Authors:  S P McKenna; L C Doward
Journal:  Pharmacoeconomics       Date:  1994-11       Impact factor: 4.981

5.  The social outcome of adults with constitutional growth delay.

Authors:  A Sartorio; F Morabito; G Peri; A Conti; G Faglia
Journal:  J Endocrinol Invest       Date:  1990 Jul-Aug       Impact factor: 4.256

Review 6.  Hormones and behaviour.

Authors:  R Fahlbusch; A Barocka
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

Review 7.  The effects of growth hormone and IGF-1 deficiency on cerebrovascular and brain ageing.

Authors:  W E Sonntag; C Lynch; P Thornton; A Khan; S Bennett; R Ingram
Journal:  J Anat       Date:  2000-11       Impact factor: 2.610

Review 8.  A critical review of dimension-specific measures of health-related quality of life in cross-cultural research.

Authors:  M J Naughton; I Wiklund
Journal:  Qual Life Res       Date:  1993-12       Impact factor: 4.147

9.  Reversal of opiate-induced apoptosis by human recombinant growth hormone in murine foetus primary hippocampal neuronal cell cultures.

Authors:  Anne-Lie Svensson; Nora Bucht; Mathias Hallberg; Fred Nyberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-12       Impact factor: 11.205

Review 10.  [Growth hormone therapy in adults. Attempt to assess a decade of use].

Authors:  M Faust; C J Strasburger
Journal:  Internist (Berl)       Date:  2008-05       Impact factor: 0.743
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.